General MedicationsORALStandard
LIVMARLI
MARALIXIBAT CHLORIDE
Standard Dose
EQ 10MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LIVMARLI is listed in Drugs@FDA under application 219485 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MARALIXIBAT CHLORIDE Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor MIRUM Submission history Latest submission status date: 2025-04-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview LIVMARLI is listed in Drugs@FDA under application 219485 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MARALIXIBAT CHLORIDE Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor MIRUM Submission history Latest submission status date: 2025-04-10 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.